ATE347546T1 - Hydroxyformamidin-derivate und diese enthaltende medikamente - Google Patents
Hydroxyformamidin-derivate und diese enthaltende medikamenteInfo
- Publication number
- ATE347546T1 ATE347546T1 AT01941061T AT01941061T ATE347546T1 AT E347546 T1 ATE347546 T1 AT E347546T1 AT 01941061 T AT01941061 T AT 01941061T AT 01941061 T AT01941061 T AT 01941061T AT E347546 T1 ATE347546 T1 AT E347546T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- formula
- substituted
- represented
- participates
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006681 (C2-C10) alkylene group Chemical group 0.000 abstract 1
- NNDIXBJHNLFJJP-UHFFFAOYSA-N 20-Hydroxyeicosatetraenoic acid Chemical compound OCCCCCC=CCC=CCC=CCC=CCCCC(O)=O NNDIXBJHNLFJJP-UHFFFAOYSA-N 0.000 abstract 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 230000010339 dilation Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000004088 microvessel Anatomy 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000180477 | 2000-06-15 | ||
| JP2000180479 | 2000-06-15 | ||
| JP2000336140 | 2000-11-02 | ||
| JP2000359781 | 2000-11-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE347546T1 true ATE347546T1 (de) | 2006-12-15 |
Family
ID=27481364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01941061T ATE347546T1 (de) | 2000-06-15 | 2001-06-15 | Hydroxyformamidin-derivate und diese enthaltende medikamente |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6670382B2 (de) |
| EP (1) | EP1291343B1 (de) |
| JP (1) | JP4904659B2 (de) |
| KR (1) | KR100776095B1 (de) |
| CN (1) | CN1177824C (de) |
| AT (1) | ATE347546T1 (de) |
| AU (2) | AU2001274535B2 (de) |
| CA (1) | CA2411418C (de) |
| DE (1) | DE60125036T2 (de) |
| DK (1) | DK1291343T3 (de) |
| ES (1) | ES2280379T3 (de) |
| WO (1) | WO2001096309A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001274535B2 (en) | 2000-06-15 | 2005-06-30 | Taisho Pharmaceutical Co., Ltd. | Hydroxyformamidine derivatives and medicines containing the same |
| US7214714B2 (en) | 2001-04-26 | 2007-05-08 | Taisho Pharmaceutical Co. Ltd. | 20-hydroxyeicosatetraenoic acid production inhibitors |
| WO2002089408A1 (en) * | 2001-05-02 | 2002-11-07 | Symbian Limited | Group communication method for a wireless communication device |
| JPWO2003022821A1 (ja) * | 2001-09-06 | 2004-12-24 | 大正製薬株式会社 | 20−hete産生酵素阻害作用を有するヘテロ環誘導体 |
| AU2003262069A1 (en) | 2002-09-12 | 2004-04-30 | Taisho Pharmaceutical Co., Ltd. | N-hydroxyformamidine derivative |
| ES2765632T3 (es) | 2005-07-29 | 2020-06-10 | Bayer Cropscience Lp | Estabilización de productos para el cuidado del cuerpo y del hogar contra la degradación por radiación UV utilizando derivados de merocianina |
| RU2532135C2 (ru) * | 2007-02-22 | 2014-10-27 | Зингента Партисипейшнс Аг | Производные иминопиридина и их применение в качестве микробиоцидов |
| BR112018015760A2 (pt) * | 2016-02-15 | 2019-01-02 | Taisho Pharmaceutical Co., Ltd. | composto de piridina substituído por azol |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959368A (en) | 1975-04-28 | 1976-05-25 | Stauffer Chemical Company | N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent |
| US3998970A (en) * | 1975-04-28 | 1976-12-21 | Stauffer Chemical Company | N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent |
| GB1594261A (en) | 1977-02-18 | 1981-07-30 | Shell Int Research | Benzyloxime ethers |
| US4079149A (en) | 1977-06-30 | 1978-03-14 | Shell Oil Company | Benzyl oxime ethers |
| IL56878A (en) | 1978-03-31 | 1984-03-30 | Rhone Poulenc Inc | Ketoximinoethers and their use as insecticides |
| US4158015A (en) | 1978-08-16 | 1979-06-12 | Mobil Oil Corporation | Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes |
| DE2907972A1 (de) | 1979-03-01 | 1980-09-11 | Bayer Ag | Omega -halogen-acetophenon-oximether, verfahren zu ihrer herstellung sowie ihre verwendung als zwischenprodukte zur herstellung von omega -azolyl-acetophenon-oximethern |
| AU6159680A (en) | 1979-08-24 | 1981-04-09 | Rhone-Poulenc, Inc. | Ketoximinoether insecticides |
| DE3005899A1 (de) | 1980-02-16 | 1981-09-03 | Hoechst Ag, 6000 Frankfurt | Derivate des 1,2,4-triazols und imidazols, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel |
| DE3044564A1 (de) | 1980-11-26 | 1982-07-15 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von (alpha)-bromacetophenonoximethern |
| US4474815A (en) | 1981-04-30 | 1984-10-02 | Commonwealth Scientific And Industrial Research Organization | Insecticidal oximes |
| US4566901A (en) | 1982-05-06 | 1986-01-28 | Ciba-Geigy Corporation | Novel oxime ethers, the preparation thereof, compositions containing them and the use thereof |
| US4434182A (en) | 1982-11-01 | 1984-02-28 | Fmc Corporation | Insecticidal substituted-biphenylmethyl oxime ethers |
| IL75858A (en) | 1984-07-31 | 1989-02-28 | Commw Scient Ind Res Org | Substituted benzyl ethers of oximes,their production and their use as arthropodicides |
| US4824476A (en) | 1985-06-24 | 1989-04-25 | Ciba-Geigy Corporation | Herbicidally active derivatives of N-phenyl-3,4,5,6-tetrahydrophthalimide |
| DE4213149A1 (de) | 1992-04-22 | 1993-10-28 | Hoechst Ag | Akarizide, insektizide und nematizide substituierte (Hetero)-Aryl-Alkyl-ketonoxim-O-ether, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel |
| US5267857A (en) | 1993-02-12 | 1993-12-07 | A-Dec, Inc. | Brightness control system for dental handpiece light |
| ES2256053T3 (es) * | 1999-11-01 | 2006-07-16 | Taisho Pharmaceutical Co., Ltd | Inhibidor de la enzima de produccion de 20-hete. |
| AU2001274535B2 (en) | 2000-06-15 | 2005-06-30 | Taisho Pharmaceutical Co., Ltd. | Hydroxyformamidine derivatives and medicines containing the same |
| US7214714B2 (en) * | 2001-04-26 | 2007-05-08 | Taisho Pharmaceutical Co. Ltd. | 20-hydroxyeicosatetraenoic acid production inhibitors |
-
2001
- 2001-06-15 AU AU2001274535A patent/AU2001274535B2/en not_active Ceased
- 2001-06-15 DE DE60125036T patent/DE60125036T2/de not_active Expired - Lifetime
- 2001-06-15 JP JP2002510452A patent/JP4904659B2/ja not_active Expired - Fee Related
- 2001-06-15 CA CA002411418A patent/CA2411418C/en not_active Expired - Fee Related
- 2001-06-15 EP EP01941061A patent/EP1291343B1/de not_active Expired - Lifetime
- 2001-06-15 AU AU7453501A patent/AU7453501A/xx active Pending
- 2001-06-15 DK DK01941061T patent/DK1291343T3/da active
- 2001-06-15 KR KR1020027016921A patent/KR100776095B1/ko not_active Expired - Fee Related
- 2001-06-15 US US10/311,003 patent/US6670382B2/en not_active Expired - Fee Related
- 2001-06-15 AT AT01941061T patent/ATE347546T1/de active
- 2001-06-15 ES ES01941061T patent/ES2280379T3/es not_active Expired - Lifetime
- 2001-06-15 WO PCT/JP2001/005108 patent/WO2001096309A1/ja not_active Ceased
- 2001-06-15 CN CNB018110126A patent/CN1177824C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20030186979A1 (en) | 2003-10-02 |
| EP1291343B1 (de) | 2006-12-06 |
| DK1291343T3 (da) | 2007-02-05 |
| KR20030010690A (ko) | 2003-02-05 |
| CA2411418A1 (en) | 2002-12-06 |
| AU2001274535B2 (en) | 2005-06-30 |
| JP4904659B2 (ja) | 2012-03-28 |
| EP1291343A4 (de) | 2004-04-07 |
| WO2001096309A1 (en) | 2001-12-20 |
| ES2280379T3 (es) | 2007-09-16 |
| CN1436173A (zh) | 2003-08-13 |
| DE60125036D1 (de) | 2007-01-18 |
| DE60125036T2 (de) | 2007-06-21 |
| US6670382B2 (en) | 2003-12-30 |
| HK1057043A1 (en) | 2004-03-12 |
| CA2411418C (en) | 2010-01-12 |
| AU7453501A (en) | 2001-12-24 |
| EP1291343A1 (de) | 2003-03-12 |
| KR100776095B1 (ko) | 2007-11-15 |
| CN1177824C (zh) | 2004-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900358A1 (ru) | Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv | |
| ATE288443T1 (de) | Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung | |
| EP1489077A4 (de) | 2- furancarbonsäurehydrazide und diese enthaltende pharmazeutische zusammensetzung | |
| BRPI9908319B8 (pt) | composto amino cíclico, composição farmacêutica, medicamento contendo um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo. | |
| MXPA02012034A (es) | Derivados de tiofeno utiles como agentes anticancerosos. | |
| NO884202D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater. | |
| KR890012649A (ko) | 아릴아미도(및 아릴티오아미도)-아자비사이클로 알칸으로 기억력을 향상시키거나 기억력 부족을 교정시키는 방법 | |
| IT1228293B (it) | Benzoderivati di composti eterociclici contenenti azoto. | |
| DE60125036D1 (de) | Hydroxyformamidin-derivate und diese enthaltende medikamente | |
| DE60137442D1 (de) | 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung | |
| ATE476431T1 (de) | Piperidin- und azetidinderivate als glyt1- inhibitoren | |
| DE69910083D1 (de) | Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten | |
| ATE181918T1 (de) | Purinderivate und ihre pharmazeutisch akzeptablen salze | |
| AU759604B2 (en) | Inhibitor for 20-hete-yielding enzyme | |
| DE60119378T8 (de) | Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten | |
| ATE215075T1 (de) | Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend | |
| AR046132A1 (es) | Composicin farmaceutica que contiene al menos un compuesto con actividad de receptor de cb1, o un profarmaco , tautomero o sal del mismo, como componente activo adecuado para el tratamiento y/o profilaxis de enfermedades relacionadas con el receptor cb1 en pacientes juveniles y/o para el tratamiento | |
| ATE66232T1 (de) | Pyrimido(5,4-b>(1,4>oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b>(1,4>oxazinderivate. | |
| TH91789A (th) | อนุพันธ์เฟนิล-1,2,4-ออกซะไดแอโซโลนที่มีหมู่เฟนิล, กรรมวิธีสำหรับการเตรียมสารเหล่านี้และการใช้สารเหล่านี้ทางเภสัชกรรม | |
| TH84545A (th) | สารรักษาโรค | |
| TH62262A (th) | สารต้านแบคทีเรีย | |
| TH68183A (th) | อนุพันธ์ไซโคลแอลคิล ที่มีหมู่ไบโอไอโซสเทอริค คาร์บอกซิลิคแอซิด, กรรมวิธีสำหรับเตรียมสารเหล่านี้และการใช้สารเหล่านี้เป็นยารักษาโรค | |
| IS7333A (is) | MMP tálmar | |
| TH65335A (th) | สารประกอบพรัยโรโล [2,3d] ไพริมิดิน | |
| TH84547A (th) | สารรักษาโรค |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1291343 Country of ref document: EP |